SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd - ADR

ADXN is trending due to news of selected clinical candidates from a GABAB collaboration, potentially unlocking milestone payments and royalties. The community is focused on the stock's low float and speculating about a potential short squeeze, with some anticipating a significant price surge. Bullish sentiment is fueled by the news catalyst and the stock's technical setup.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is trending as the community discusses the Gravity SUV deliveries and their impact on the company's future. Investors are weighing the potential of new partnerships and production targets against concerns about dilution and cash flow. Sentiment appears mixed, with some highlighting the quality of Lucid's vehicles while others express skepticism about the company's financial health and management.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending downwards, driven by concerns surrounding a CEO stock sale and broader sector pressures related to potential price cuts on weight loss drugs. Community sentiment is largely negative, with some accusing the CEO of exploiting retail investors, while others see a buying opportunity amidst the volatility. The stock is experiencing a significant sell-off, leading to active discussions about potential support levels and future price direction.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending due to its low float, regained NASDAQ compliance, and a recently announced, record-breaking contract. The stock is being compared to other low-float Hong Kong stocks that have experienced significant short squeezes, with traders noting the high cost to borrow and potential for a similar move. The community is actively discussing its potential for a substantial run.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending downwards, with community sentiment reflecting concerns about insider selling and a lack of communication from management. Some traders are expressing frustration and considering exiting their positions, while others see the dip as a buying opportunity. Discussions include potential price targets and comparisons to similar stocks, with a focus on the company's financial health and future prospects.

Firecoin is a digital asset inspired by the concept of the eternal flame, representing energy, resilience, and guidance. It is designed to act as a decentralized token that embodies light and strength, giving holders a sense of empowerment in the digital economy. The project’s purpose is to create a community-driven ecosystem where Firecoin symbolizes progress, illumination, and the ability to move forward regardless of challenges. By leveraging blockchain technology, Firecoin aims to provide transparency, security, and accessibility to its users while maintaining its thematic connection to the symbolic power of fire.

firecoin

$FIRECOIN is trending due to increasing attention within the Phantom Wallet community, with many users highlighting its potential for significant gains. The community is actively discussing its availability on Phantom Wallet and anticipating a potential 'moonshot,' while some users are raising concerns about potential scams.

Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. It operates through Network Business and Hospital Business segments. It provides radiotherapy and diagnostic equipment leasing services to hospitals, and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Concord Medical Services - ADR

Concord Medical Services Holdings Limited

Concord Medical (CCM) is trending due to speculation around low float and potential for a significant price move, similar to other recent runners. The community is actively discussing its potential as a Chinese stock play, with some highlighting its commercial eye cancer therapy and high cost to borrow (CTB). Recent news regarding proton therapy and procurement licenses may also be contributing to the increased interest.

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Mind Medicine Inc

Mind Medicine Inc - Ordinary Shares (Sub Voting)

MNMD is trending as the community discusses potential catalysts, including positive trial data and regulatory developments in the psychedelics sector.  Bullish sentiment is fueled by the anticipation of significant price appreciation and potential buyouts, with the company's strong cash position and ongoing Phase 3 trials cited as key factors. Discussions also involve the broader context of psychedelic medicine's growing acceptance and potential to revolutionize mental health treatment.

Carbon Revolution Plc engages in the manufacturing of advanced carbon fiber wheels. The firm is currently supplying wheels to the automotive market for vehicles and SUVs and is developing wheels for EVs under contract for its OEM customers. The company is headquartered in Dublin, Ireland.

Carbon Revolution Public Ltd. Co.

Carbon Revolution

CREV is trending due to a recently announced $25 million financing agreement, sparking significant pre-market volume and a price surge. The community is actively discussing the potential for a short squeeze, with some speculating on price targets and others noting the stock's volatility and potential dilution risks. Bullish sentiment is fueled by the news, while bears caution about the company's financials.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending as traders discuss its potential after receiving FDA Fast Track designation for its AlloNK therapy, with some highlighting a low float and analyst price target increases. Community members are weighing potential offerings against the positive news and technical patterns. The focus is on the company's prospects in autoimmune disease treatment and the potential for a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLRPF Phase 2 trial w/est Sep completion date NCT05613842: https://www.clinicaltrials.gov/study/NCT05613842 Trial Tracker: https://www.fdatracker.com/trial-tracker/

Clinicaltrials

CTG Labs - NCBI

Sign up or log in to access Trial Tracker! This limited demo only displays Phase 3 trials with primary completion dates within the last 3 months for companies with a market cap less than $1B. FDA Tracker Membership unlocks all of the selection criteria to help you screen the full range of clinical trial catalysts.